tirzepatide vs semaglutide cardiovascular 💉 In a large real-world study, was associated with a lower incidence of major outcomes semaglutide: 📊 Composite CV outcome: 1.90% vs 2.18% (HR 0.86, p=0.01) ❤️ New-onset heart Diabetes drugs semaglutide and tirzepatide

These low serum carnitine levels in cachectic patients contribute to the progression of the condition in cancer patients [21]

In vitro assays involving fecal slurries supplemented with the fermentation product demonstrated a reduction in TMA levels, and the NGS analysis revealed that Collinsella , Clostridium , and Streptococcus were the most common bacterial genera that produced TMA

Emerging research suggests these drugs can lower systemic inflammation and improve insulin resistance in conditions like PCOS (polycystic ovary syndrome) even at lower doses

It belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists